|
Volumn 483, Issue 7389, 2012, Pages 269-
|
A plan for mental illness
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN D;
ATTENTION DEFICIT DISORDER;
AUTISM;
CLINICAL EFFECTIVENESS;
COGNITION;
COGNITIVE THERAPY;
DISABILITY;
GENETIC ANALYSIS;
GENETIC VARIABILITY;
HUMAN;
MAJOR DEPRESSION;
MENTAL DISEASE;
MENTAL HEALTH;
MENTAL HEALTH RESEARCH;
NOTE;
PHOBIA;
PRIORITY JOURNAL;
PROTEIN TARGETING;
PSYCHOPHARMACOLOGY;
PSYCHOPHARMACOTHERAPY;
RISK FACTOR;
SCHIZOPHRENIA;
SICKLE CELL ANEMIA;
SOCIAL INTERACTION;
SUBSTANCE ABUSE;
SUICIDE;
TREATMENT PLANNING;
VIRTUAL REALITY;
ANIMAL;
ARTICLE;
CLINICAL TRIAL (TOPIC);
DISEASE MODEL;
DRUG INDUSTRY;
ECONOMICS;
GENETICS;
IMPULSIVENESS;
MANPOWER;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
NEUROSCIENCE;
STATISTICS;
TRANSLATIONAL RESEARCH;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
COGNITIVE THERAPY;
DISEASE MODELS, ANIMAL;
DRUG INDUSTRY;
HUMANS;
IMPULSIVE BEHAVIOR;
MENTAL DISORDERS;
MOLECULAR TARGETED THERAPY;
NEUROSCIENCES;
TRANSLATIONAL MEDICAL RESEARCH;
|
EID: 84858264050
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/483269a Document Type: Note |
Times cited : (55)
|
References (10)
|